Error message

Error connecting with: asu_cs.

Integrated Search Menu

Kenneth Buetow

Professor; Director, Computational Science and Informatics Core Program, Complex Adaptive Systems Initiative
Faculty, Tempe Campus, Mailcode 4804
Director (FSC) & Professor
Faculty, Tempe Campus, Mailcode 4804
Director (FSC) & Professor
Faculty, TEMPE Campus, Mailcode 4804
Director (FSC) & Professor
Faculty w/Admin Appointment, TEMPE Campus, Mailcode 4804
Biography

Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. He currently serves as Director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU), is a professor in the School of Life Sciences in ASU’s College of Liberal Arts and Sciences; is a Core Faculty in ASU’s Center for Evolution and Medicine; and is Director of Bioinformatics and Data Management for the National Biomarker Development Alliance.

Buetow previously served as the founding Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health’s National Cancer Institute.

Education

Indiana University, BA, 05/1980 , Biology
University of Pittsburgh, MS, 05/1983, Human Genetics
University of Pittsburgh, PhD, 12/1985, Human Genetics

Publications
  • Abernethy A, Abrahams E, Barker A, Buetow K, Burkholder R, Dalton WS, Foti M, Frueh F, Gaynor RB, Kean M, Khan Z, Lessor T, Lichtenfeld JL, Mendelsohn J, van't Veer L. Turning the Tide Against Cancer Through Sustained Medical Innovation: The Pathway to Success. Clin Cancer Res (2014).
  • Chen QR, Hu Y, Yan C, Buetow K, Meerzaman D. Systematic Genetic Analysis Identifies Cis-eQTL Target Genes Associated with Glioblastoma Patient Survival. PLoS One (0).
  • Meerzaman DM, Yan C, Edmonson MN, Schaefer CF, Clifford RJ, Dunn BK, Dong L, Finney RP, Cultraro CM, Hu Y, Yang Z, Nguyen CV, Kelley JM, Cai S, Zhang H, Zhang J, Wilson R, Messmer L, Chen QR, Chung YH, Kim JA, Park NH, Lyu MS, Song IH, Buetow KH. Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma (HCC). Cancer Genomics Proteomics (0).
  • Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, Jain R, Colen R, Rubin DL, Zinn PO, Hwang SN, Raghavan P, Hammoud DA, Scarpace LM, Mikkelsen T, Chen J, Gevaert O, Buetow K, Freymann J, Kirby J, Flanders AE, Wintermark M;. Addition of MR Imaging Features and Genetic Biomarkers Strengthens Glioblastoma Survival Prediction in TCGA Patients. J Neuroradiol (0).
Research Activity
  • Buetow,Kenneth H*. Phase II: A Multiple Sclerosis Patient-Powered Research Network. ACP(9/5/2015 - 9/4/2018).
  • Buetow,Kenneth H*. A Multiple Sclerosis Patient-Powered Research Network. ACP(3/1/2014 - 11/30/2015).
  • Buetow,Kenneth H*. Immune Simulator for in silico research relevant to immune-based oncology drug targets. BRISTOL-MYERS-SQUIBB CO(12/3/2013 - 12/2/2016).
Service
  • Working Group Research Computing (WGRC), Member (2015 - Present)
  • Research Computing Steering Committee, Member (2015 - Present)
  • Analytics@ASU Academics Task Force, Member (2015 - Present)
  • Analytics@ASU Research Task Force, Member (2015 - Present)
  • International GBM AGILE (Adaptive Global Innovative Learning Environment) Data Management/Database Development/Statistical Core, Co-Chair (2015 - Present)
  • National Biomarker Development Alliance Steering Committee, committee member (2014 - Present)
  • National Biomarker Development Alliance Steering Committee, committee member (2014 - Present)
  • OHSL Council of Advisers for Science and Technology, committee member (2014 - Present)
  • OHSL Council of Advisers for Science and Technology, committee member (2014 - Present)
  • IO Bridge Molecular Profiling and Bioinformatics Advisory Group, Bristol-Myers Squibb Company, committee member (2013 - Present)
  • IO Bridge Molecular Profiling and Bioinformatics Advisory Group, Bristol-Myers Squibb Company, committee member (2013 - Present)
  • IO Bridge Molecular Profiling and Bioinformatics Advisory Group, Bristol-Myers Squibb Company, committee member (2013 - Present)
  • DataNet Federation Consortium Advisory Board, committee member (2013 - Present)
  • DataNet Federation Consortium Advisory Board, committee member (2013 - Present)
  • DataNet Federation Consortium Advisory Board, committee member (2013 - Present)
  • Data Liquidity Coalition Steering Committee, committee member (2013 - Present)
  • Data Liquidity Coalition Steering Committee, committee member (2013 - Present)
  • Data Liquidity Coalition Steering Committee, committee member (2013 - Present)
  • Life Sciences Research Program Advisory Committee, Internet2, committee member (2013 - Present)
  • Life Sciences Research Program Advisory Committee, Internet2, committee member (2013 - Present)
  • Turning the Tide against Cancer Advisory Committee, committee member (2011 - Present)
  • Turning the Tide against Cancer Advisory Committee, committee member (2011 - Present)
  • Turning the Tide against Cancer Advisory Committee, committee member (2011 - Present)
  • Life Sciences Research Program Advisory Committee, Internet2, committee member (2013 - 2015)
  • DHHS Multi-Payer Claims Database Governance Committee Secretary, Seceratary (2012 - 2013)